易明医药(002826.SZ)：拟推340.38万股限制性股票激励计划

Core Viewpoint - Yiming Pharmaceutical (002826.SZ) announced a restricted stock incentive plan for 2026, aiming to enhance employee motivation and align their interests with shareholders [1] Group 1: Incentive Plan Details - The incentive plan proposes to grant a total of 3.4038 million restricted shares, which accounts for approximately 1.79% of the company's total share capital of 190.677750 million shares as of the announcement date [1] - A total of 26 individuals will be granted restricted shares under this plan, indicating a targeted approach to incentivizing key personnel [1] - The initial grant price for the restricted shares is set at 10.23 yuan per share, establishing a clear entry point for the incentive [1]